US-based DEKA Medical has recently received clearance from the US Food and Drug Administration (FDA) for its Synchro REPLA: Y laser, designed for a variety of aesthetic treatments.

The FDA clearance is for its combined laser and light-based hair reduction and skin treatment for benign pigmented lesions, wrinkles and photocoagulation of vascular lesions.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The new Synchro system uses three different light sources, a 755nm Alexandrite laser, a 1064nm Nd:YAG laser and an intense pulsed light, that can remove hair and perform skin treatments such as rejuvenation and treatment of vascular lesions.

"The energies, varying pulse widths and pulse shape and the large spot sizes represent an advancement in technology, that results in faster, better tolerated and more reliable treatments."

Lasers feature spot sizes from 2.5mm to 20mm, while the intense pulsed light includes five filters, from 500nm to 650nm lower cut-off wavelength, allowing a broad range of effective and safe treatments.

The powerful, fast, complete Synchro REPLA: Y system combines hair removal on all Fitzpatrick skin types, including tanned skin, vascular and benign pigmented lesions treatments, as well as skin rejuvenation, in a single platform.

American Society for Laser Medicine and Surgery fellow director of Kassir Dermatology, Dallas, Texas, Dr Martin Kassir said: "The energies, varying pulse widths and pulse shape and the large (20 mm) spot sizes represent an advancement in technology, that results in faster, better tolerated and more reliable treatments.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

"I am very excited to be the first dermatologist in North America to use the Synchro REPLA:Y and to offer its benefits to my patients."

The Synchro REPLA: Y anticipates the future, including for the first time in one system one powerful (125W) and fast (3Hz, while the industry standard is still 2Hz) Alexandrite laser, together with one powerful (150W) and fast Nd:YAG laser with unrivaled characteristics.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact